UPB CIK: 2022626

Upstream Bio, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY22 – FY25
(positive)
millions USD
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY22 to FY25
millions USD
FY22:
−23.9
FY23:
−40.1
FY24:
−77.8
FY25:
−160
(positive)
Change from FY22 to FY25
millions USD
FY22:
−23.9
FY23:
−40.1
FY24:
−77.7
FY25:
−160
(positive)
Change from FY22 to FY25
millions USD
FY22:
−23.9
FY23:
−20.5
FY24:
−62.8
FY25:
−143
(positive)
Change from FY22 to FY25
millions USD
FY22:
−23.9
FY23:
−20.5
FY24:
−62.8
FY25:
−143

All amounts in millions USD FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far. Data sources:SEC EDGARTwelve Data